Shots: Novartis has discontinued its clinical trial HCQs due to feasibility of recruitment. The recruitment challenge has made it unlikely that the clinical team will be able to collect meaningful […]readmore
Tags : Amid
Shots: The expanded program offers access to any branded BMS’s therapies for free, including its most widely prescribed therapies and those prescribed via telehealth services Patients can reach to BMS’ […]readmore
Shots: Amgen anticipates no disruption in its supply of medicines for patients across the globe due to COVID-19 and is expected to have no shortage of its therapies The company […]readmore